We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wavefront Technology Benefits Presbyopia Sufferers

By Biotechdaily staff writers
Posted on 20 Feb 2007
Progressive lenses developed using wavefront technology offer significant improvements over standard lenses for treating presbyopia, according to a new study.

A researcher with the Ophthalmic Consultants of Long Island (OCLI; Lynbrook, NY, USA) cited a 609-person study that showed 72% of patients reported better or clearly better near vision with the wavefront-optimized progressive lenses. More...
Additionally, the study revealed that 67% reported better or clearly better distance vision and 65% reported better or clearly better intermediate vision. Wavefront-optimized lenses also had three times less distance distortion and reduced astigmatism for an intermediate viewing area, allowing it to be 30% wider.

Wavefront technology can also correct many of the low-light vision problems such as ghosting and halos that are common in traditional progressive lenses. Fine-tuning wavefront optics brings sharper vision, less blurring, and overall enhanced performance to progressive lenses. The study was presented at the American Academy of Ophthalmology 2006 Joint Meeting, held during November 2006 in Las Vegas (NV, USA).

"In the study, wavefront optimized lenses provided improved near view optics because they offered better control of the correction,” said data presenter Marguerite McDonald, M.D., a leading researcher in ophthalmology and wavefront technology, and a former professor of ophthalmology at the Louisiana State University (LSU; Baton Rouge, LA, USA) Eye Center. "Wavefront-optimized lenses correct the lens itself so that when light passes through on the way to the eye, less distortion occurs. The result is sharper vision and more generously sized viewing areas at near, intermediate, and distance.”

Presbyopia, also known as the over 40 near blur syndrome, is a refractive condition in which there is a diminished power of accommodation arising from loss of elasticity of the crystalline lens, as occurs during aging. The condition usually becomes significant after age 45.





Related Links:
Ophthalmic Consultants of Long Island
Louisiana State University

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Automatic CLIA Analyzer
Shine i6000
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.